Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 611 JPY 3.34% Market Closed
Market Cap: 39.9B JPY
Have any thoughts about
Fuji Pharma Co Ltd?
Write Note

Fuji Pharma Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fuji Pharma Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Revenue
ÂĄ46.1B
CAGR 3-Years
11%
CAGR 5-Years
5%
CAGR 10-Years
5%
Takeda Pharmaceutical Co Ltd
TSE:4502
Revenue
ÂĄ4.5T
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
10%
Daiichi Sankyo Co Ltd
TSE:4568
Revenue
ÂĄ1.8T
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
8%
Otsuka Holdings Co Ltd
TSE:4578
Revenue
ÂĄ2.3T
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Revenue
ÂĄ1.1T
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Revenue
ÂĄ1.8T
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
4%
No Stocks Found

Fuji Pharma Co Ltd
Glance View

Market Cap
39.2B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
1 987.31 JPY
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Revenue?
Revenue
46.1B JPY

Based on the financial report for Sep 30, 2024, Fuji Pharma Co Ltd's Revenue amounts to 46.1B JPY.

What is Fuji Pharma Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
5%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Fuji Pharma Co Ltd have been 11% over the past three years , 5% over the past five years , and 5% over the past ten years .

Back to Top